The highly pathogenic bird flu (H5N1), not only invades mammalian brains but can also enter the human central nervous system, creating major complications in Parkinson’s and Alzheimer’s diseases.
While treatment primarily targets symptom management, those with a chronic disorder of the autonomic nervous system, involving degenerative central nervous system (CNS) components, tend to have a less favorable long-term outlook.
Hyderabad: Back in April 2021, a macaque named Pager played a video game on a computer with its mind. This is not a scene out of a science-fiction movie, but was part of the demonstration of Neuralink, a ‘game-changing’ technology that can potentially enable quadriplegics to operate computers and smart mobile devices with their minds. […]
Vienna: How long someone lives with Parkinson’s disease may be down to specific gene mutations, according to new research presented at the ongoing 8th European Academy of Neurology (EAN) Congress in Austria. Scientists from four institutes in Paris, including the prestigious Paris Brain Institute at the Sorbonne Universite, studied the records of 2,037 Parkinson’s disease […]
Geneva: Scientists from the University of Geneva have identified a key protein in flies, and also in mice, which plays a protective role against Parkinson’s disease and could be a new therapeutic target. The study was published in the journal, ‘Nature Communication’. Parkinson’s disease is a neurodegenerative disorder characterized by the destruction of a specific […]
Parkinson's disease is a progressive nervous system disorder that affects the movement of the human body. Symptoms start gradually, sometimes starting with a barely noticeable tremor in just one hand.
"What cytisine does is it binds to target receptors but doesn't activate them as efficiently as nicotine," said researcher Rahul Srinivasan from the Texas A&M University in the US.
